- MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis
Jin‐Dan Kai et al, 2022, Cell Biology International CrossRef - Rapamycin Regulates Lipopolysaccharide-Induced Microglial Phagocytosis In Vitro
S. J. Yang et al, 2024, Molecular Biology CrossRef - Therapeutic benefits of Salvia species: A focus on cancer and viral infection
Chinonso Anthony Ezema et al, 2022, Heliyon CrossRef - A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways
Zhou Jiang et al, 2024, GeroScience CrossRef - Role of sirtuins in esophageal cancer: Current status and future prospects
Ryota Otsuka et al, 2022, World Journal of Gastrointestinal Oncology CrossRef - Effect of rapamycin on human periodontal ligament stem cells that have been exposed to sodium hypochlorite
Mohamed M. Elashiry et al, 2023, Life Sciences CrossRef